Skip to content

Clinical trials

Phase 2 Melanoma trials in Greece

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Melanoma Phase: Phase 2 Country / region: Greece Clear all

11 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20081
20141
20151
20162
20191
20201
20221
20232
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed6
Active, not recruiting2
Terminated2
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Amgen2
Bristol-Myers Squibb2
Fondazione Melanoma Onlus1
GlaxoSmithKline1
Hoffmann-La Roche1
Incyte Corporation1
Iovance Biotherapeutics, Inc.1
Merck Sharp & Dohme LLC1
University Hospital, Essen1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Melanoma11
Carcinoma, Non-Small-Cell Lung2
Neoplasm Metastasis2
Carcinoma, Hepatocellular1
Carcinoma, Renal Cell1
Squamous Cell Carcinoma of Head and Neck1

Trials

Showing 1 to 11 of 11. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.